Literature DB >> 33407328

Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD.

Li Lin1, Jianxin Shi1, Jian Kang1, Qiuyue Wang2.   

Abstract

BACKGROUND: For patients with acute exacerbation of COPD (AECOPD), type 2 diabetes mellitus (T2DM) as comorbidity have poor outcomes. However, data on the impact of previously diagnosed and new- diagnosed T2DM in such a patient population is lacking.
METHODS: Inpatients diagnosed with AECOPD in the department of Pulmonary and Critical Care Medicine of The First Hospital of China Medical University during 2011-2017 were enrolled. Data on demography, prevalence of type 2 DM, other comorbidities, hospital stays and laboratory tests (including arterial partial pressure of oxygen [PaO2]) results were recorded. Results were compared with AECOPD patients having previously diagnosed and new-diagnosed type 2 diabetes. Markers associated with development of type 2 DM and the prognosis of AECOPD patients were identified.
RESULTS: Of the 196 patients enrolled in this study, the overall prevalence of T2DM was 26%. The PaO2 in the newly diagnosed T2DM group was considerably lower versus non-diabetic group. The T2DM group had a longer hospital stay and higher troponin level versus the non-diabetic group. AECOPD patients with T2DM were found to be correlated with hypertension. Age, need for assisted ventilation, increased troponin, and elevated fasting blood glucose on admission were risk factors for death in hospitalized AECOPD patients.
CONCLUSIONS: AECOPD patients had a higher prevalence of T2DM than the general population; T2DM comorbidity caused lower PaO2, longer hospital stays, and increased troponin. Poor blood glucose control may increase the risk of death in AECOPD patients.

Entities:  

Keywords:  Acute exacerbation of COPD; COPD; Coronary heart disease; Diabetes mellitus; Hypertension; Short-term prognosis

Year:  2021        PMID: 33407328     DOI: 10.1186/s12890-020-01371-9

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  38 in total

1.  Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD.

Authors:  Ali Parappil; Barbara Depczynski; Peter Collett; Guy B Marks
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

Review 2.  Epidemiology of chronic obstructive pulmonary disease (COPD).

Authors:  G Viegi; A Scognamiglio; S Baldacci; F Pistelli; L Carrozzi
Journal:  Respiration       Date:  2001       Impact factor: 3.580

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

4.  Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Heikki O Koskela; Päivi H Salonen; Leo Niskanen
Journal:  Clin Respir J       Date:  2013-07-31       Impact factor: 2.570

5.  High Prevalence of Diabetes Mellitus in a Cohort of Patients with Chronic Obstructive Pulmonary Disease in Trinidad, West Indies.

Authors:  Kirin Rambaran; Bryan Bhagan; Amanda Ali; Firas Ali; Shivan Toolsie; Rekha Lobin; Shivani Beharry; Sabrina Ghany; Saeeda Mohammed; Gershwin Davis; Sateesh Sakhamuri; Surujpal Teelucksingh; Terence Seemungal
Journal:  Turk Thorac J       Date:  2019-01-01

Review 6.  Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.

Authors:  Carlos H Martinez; MeiLan K Han
Journal:  Med Clin North Am       Date:  2012-03-22       Impact factor: 5.456

7.  Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.

Authors:  Samy Suissa; Sophie Dell'Aniello; Pierre Ernst
Journal:  Thorax       Date:  2012-06-08       Impact factor: 9.139

Review 8.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

9.  Determining prognosis in acute exacerbation of COPD.

Authors:  Yves Flattet; Nicolas Garin; Jacques Serratrice; Arnaud Perrier; Jérome Stirnemann; Sebastian Carballo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-31

10.  Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.

Authors:  Te-Wei Ho; Chun-Ta Huang; Sheng-Yuan Ruan; Yi-Ju Tsai; Feipei Lai; Chong-Jen Yu
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

View more
  2 in total

1.  Characteristics of patients referred to Canary Island pneumology outpatient services for chronic obstructive pulmonary disease: the EPOCan study.

Authors:  Juan Marco Figueira-Gonçalves; José María Hernández-Pérez; Carlos Cabrera-López; Aurelio Luis Wangüemert-Pérez; Ignacio García-Talavera; Yolanda Ramallo-Fariña; Carolina Ramos-Izquierdo; Luis Manuel González-García; Sara Guanche-Dorta
Journal:  BMC Res Notes       Date:  2022-02-10

2.  Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program.

Authors:  Ying-Yi Chen; Tsai-Chung Li; Chia-Ing Li; Shih-Pin Lin; Pin-Kuei Fu
Journal:  J Pers Med       Date:  2022-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.